THE INFLUENCE OF PERIOPERATIVE ADMINISTRATION OF DEXMEDETOMIDINE ON INFLAMMATION RESPONSE AND POSTOPERATIVE OUTCOMES IN PATIENTS UNDERGOING HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) CYTOREDUCTIVE SURGERY; DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL: